Sign Up to like & get
recommendations!
1
Published in 2017 at "European Radiology"
DOI: 10.1007/s00330-017-5294-x
Abstract: ObjectivesTo develop criteria to improve discrimination between vertebral metastases from neuroendocrine tumours (NETs) and benign bone lesions on PET combined with CT using DOTA-D-Phe1-Tyr3-octreotide labelled with gallium-68 (68Ga-DOTA-TOC).MethodsIn 535 NET patients, 68Ga-DOTA-TOC PET/CT examinations were…
read more here.
Keywords:
toc pet;
68ga dota;
vertebral metastases;
dota toc ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-3362
Abstract: Purpose: PET with somatostatin receptor ligand [68Ga]Ga-DOTA-D-Phe1-Tyr3-octreotide ([68Ga]Ga-DOTA-TOC) is an established method in radiotherapy planning because of the improved detection and delineation of meningioma tissue. We investigated the diagnostic accuracy of supplementary [68Ga]Ga-DOTA-TOC PET in…
read more here.
Keywords:
68ga dota;
dota toc;
toc pet;